Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment.
CONCLUSION: In the present study we observed that IBD patients assigned to an intensified dosing interval during maintenance therapy have significantly higher IFX TL than patients receiving conventional 8 week interval. Patients with UC had significantly higher IFX TL.
PMID: 30645913 [PubMed - in process]
Source: Acta Gastro-Enterologica Belgica - Category: Gastroenterology Tags: Acta Gastroenterol Belg Source Type: research
More News: Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Laboratory Medicine | Remicade | Slovakia Health | Study | Ulcerative Colitis